Roger B. Peck

Evaluation of an IgG deficiency rapid screening test among Pakistani children with primary immunodeficiency (PID)

Ali Faisal Saleem, Allison Golden, Zaubina Kazi, Syeda Mahjabeen Zehra et autres

pk, us (code pays fourni par la source)

Leveraging HIV Research Infrastructure for Lung Disease Screening by Spirometry in Tanzania

Jonah Susser Kreniske, Grace Ruselu, Amy Hideko Kaji, Lamidi Rasheed Emmanuel et autres

Abstract Introduction: HIV drives increased susceptibility to tobacco-induced COPD, yet most people with HIV (PWH) live in regions with where tobacco is uncommon, such as sub-Saharan Africa. The impact of HIV on COPD in low-smoking populations remains uncertain, partly due to limited …

us, Tanzanie (code pays fourni par la source)

Urine lipoarabinomannan concentrations among HIV-negative adults with pulmonary or extrapulmonary tuberculosis disease in Vietnam

Hoa Binh Nguyen, Mark Fajans, Hùng Nguyễn Văn, Bao Vu Ngoc et autres

Lipoarabinomannan (LAM) is a promising target biomarker for diagnosing subclinical and clinical tuberculosis (TB). Urine LAM (uLAM) testing using rapid diagnostic tests (RDTs) has been approved for people living with HIV (PLWH), however there is limited data regarding uLAM levels in HIV-negative …

vn, us, ch (code pays fourni par la source)

Correction: Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

Jason L. Cantera, Lorraine M. Lillis, Roger B. Peck, Emmanuel Moreau et autres

[This corrects the article DOI: 10.1371/journal.pone.0274415.].

ca, tw (code pays fourni par la source)

From biorepositories to data repositories: Open-access resources accelerate early R&D and validation of equitable diagnostic tools

Roger B. Peck, Helen L. Gerns Storey, Becky Barney, Shirli Israeli et autres

Diagnostics are critical tools that guide clinical decision-making for patient care and support disease surveillance. Despite its importance, developers and manufacturers often note that access to specimen panels and essential reagents is one of the key challenges in developing quality diagnostics, particularly …

us (code pays fourni par la source)

Urine lipoarabinomannan concentrations among HIV-uninfected adults with pulmonary or extrapulmonary tuberculosis disease in Vietnam

Mark Fajans, Hùng Nguyễn Văn, Bao Vu Ngoc, Hòa Nguyễn Thị et autres

Abstract Lipoarabinomannan (LAM) is a Mycobacterial cell wall glycolipid excreted in urine, and a target biomarker of rapid diagnostic tests (RDTs) for tuberculosis (TB) disease. Urine LAM (uLAM) testing by RDT has been approved for people living with HIV, but there is …

vn, us, ch (code pays fourni par la source)

A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen-Based Diagnostic Tests for COVID-19

Allison Golden, Jason L. Cantera, Lorraine Lillis, Thanh T. Phan et autres

This study reports the results for severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) nucleocapsid (N) and spike (S) antigen quantification assays and their performance against clinical reverse transcription (RT)-PCR results, thus describing an open-access quantification method for two important SARS-CoV-2 protein analytes. Characterized …

us (code pays fourni par la source)

Development of an approach to monitor the manufacturing consistency of HIV rapid diagnostic tests: Panel qualification and potential impact on country programs

David W. Jenkins, Roger B. Peck, Ashini Fernando

Although regulatory bodies have standards that manufacturers of rapid diagnostic tests (RDTs) must meet for market approval, RDTs have no specific sampling and testing standards to monitor ongoing lot production, unlike pharmaceuticals and certain devices. With the importance of accurate diagnosis for …

us (code pays fourni par la source)

Data from An Evaluation of Novel, Lower-Cost Molecular Screening Tests for Human Papillomavirus in Rural China

Fanghui Zhao, José Jerónimo, You‐Lin Qiao, Johannes Schweizer et autres

Abstract New, lower-cost tests that target high-risk human papillomavirus (HR-HPV) have been developed for cervical cancer screening in lower-resource settings but large, population-based screening studies are lacking. Women ages 25 to 65 years and living in rural China (n = 7,543) self-collected …

Supplementary Tables 1 - 2 from An Evaluation of Novel, Lower-Cost Molecular Screening Tests for Human Papillomavirus in Rural China

Fanghui Zhao, José Jerónimo, You‐Lin Qiao, Johannes Schweizer et autres

PDF file - 107K, Supplemental Tables 1A and 1B: Agreement between worst study histopathologic diagnosis. Supplemental Table 2: The relationship of E6 and DNA detection of human papillomavirus (HPV) genotypes 16, 18, and/or 45 (HPV16/18/45) on cervical exfoliated cells with HPV genotypes …

Supplementary Tables 1 - 2 from An Evaluation of Novel, Lower-Cost Molecular Screening Tests for Human Papillomavirus in Rural China

Fanghui Zhao, José Jerónimo, You‐Lin Qiao, Johannes Schweizer et autres

PDF file - 107K, Supplemental Tables 1A and 1B: Agreement between worst study histopathologic diagnosis. Supplemental Table 2: The relationship of E6 and DNA detection of human papillomavirus (HPV) genotypes 16, 18, and/or 45 (HPV16/18/45) on cervical exfoliated cells with HPV genotypes …

Data from An Evaluation of Novel, Lower-Cost Molecular Screening Tests for Human Papillomavirus in Rural China

Fanghui Zhao, José Jerónimo, You‐Lin Qiao, Johannes Schweizer et autres

Abstract New, lower-cost tests that target high-risk human papillomavirus (HR-HPV) have been developed for cervical cancer screening in lower-resource settings but large, population-based screening studies are lacking. Women ages 25 to 65 years and living in rural China (n = 7,543) self-collected …